Document is current
Any future updates will be listed below
-
Authors
Horita, Shinya
Saki, Mayumi
Takigawa, Sotaro
Kanai, Yasumasa
Murotani, Kenta
Gomi, Fumi
-
Funding
Funding for this research was provided by:
Kyowa Kirin Co., Ltd.
- License Information
-
More Information
Article History
Received: 12 November 2025
Accepted: 30 March 2026
First Online: 15 April 2026
Declarations
:
: Not applicable.
: Not applicable.
: SH, MS, ST, and YK are employees of Kyowa Kirin Co., Ltd. KM reports receiving consulting fees from Kyowa Kirin Co., Ltd. FG has received financial support from Kyowa Kirin Co., Ltd., has received grants from Alcon Japan Ltd, JINS HOLDINGS Inc., and NIDEK CO., LTD, is a consultant for Kyowa Kirin Co., Ltd., has received honoraria or payment for lectures from Bayer Yakuhin, Ltd, Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Novartis Pharma K.K., Santen Pharmaceutical Co., Ltd., and Senju Pharmaceutical Co., Ltd., has received travel expenses from Santen Pharmaceutical Co., Ltd. and Senju Pharmaceutical Co., Ltd., has participated in data safety monitoring or advisory boards for Nippon Boehringer Ingelheim Co., Ltd., and has received other support from Chugai Pharmaceutical Co., Ltd., Novartis Pharma K.K., and Senju Pharmaceutical Co., Ltd.
